IMMUMEDIC · Plataforma europea de información sobre terapia con células dendríticas · Sin promesas de curación
Studys & Evidenz

Scientific Orientation

The evidence for dendritic-cell approaches is tumour-specific and heterogeneous. Studys are therefore assessed according to tumour type, study design, patient population and endpoints.

Appropriate primary sources

  • PubMed / MEDLINE
  • ClinicalTrials.gov
  • EU Clinical Trials
  • EMA and national medicines authorities
  • Guidelines of Oncology Societies

What does a study link mean?

A link to a publication or study does not mean that the described therapy is suitable or effective for a specific person. Inclusion criteria, tumour type, study design, comparator group, endpoints and transferability are decisive.

Study links in the free orientation service

Where professionally appropriate, two to three relevant primary sources or trial-registry entries may be added. This is an information service and not an individual treatment prescription.

ORIENTACIÓN

¿Paciente o profesional sanitario?

Ambas vías se mantienen separadas para que cada consulta pueda dirigirse correctamente.

Llamar a Rita+49 30 439 792 5331